期刊文献+

喹硫平合并艾司西酞普兰对伴有抑郁症状的首发精神分症患者的疗效观察 被引量:2

下载PDF
导出
摘要 目的:探讨喹硫平合并艾司西酞普兰对伴有抑郁症状的首发精神分裂症患者的临床疗效.方法:将90例伴有抑郁症状的首发精神分裂症患者随机分为两组,每组45例,分别为研究组口服喹硫平与艾司西酞普兰治疗,对照组只给予喹硫平.在治疗前及治疗8周时采用阳性与阴性症状量表、CDSS评定临床疗效,副反应量表定不良反应.结果:研究组在第8周PANSS、CDSS评分均显著低于对照组P<0.05,研究组临床有效率显著高于对照组,两组间副反应未见明显的差异.结论:喹硫平合并艾司西酞普兰对伴有抑郁症状的首发精神分裂症患者疗效显著.
出处 《临床心身疾病杂志》 CAS 2016年第S1期359-360,共2页 Journal of Clinical Psychosomatic Diseases
  • 相关文献

参考文献3

二级参考文献39

  • 1徐裕,余利霞,王忠良,毛福荣.舍曲林联合喹硫平治疗精神分裂症阴性症状疗效观察[J].中国全科医学,2009,12(14):1272-1273. 被引量:8
  • 2Addington D,Addington J,Atkinson M.Apsychometric com-parison of the Calgary Depression Scalefor Schizophrenia andthe Hamilton Depression Rating Scale[].Schizophrenia Research.1996
  • 3Bressan RA,Chaves AC,Shirakawa I,et al.Validity study of the Brazilian version of the Calgary Depression Scale for Schizophrenia[].Schizophrenia Research.1998
  • 4Lancon C,Auquier P,Reine G,et al.Study of the concurrent validity of the Calgary Depression Scale for schizophyrenica(CDSS)[].Journal of Affective Disorders.
  • 5Addington D,Addington J,Schissel B.A depression rating scale for schizophrenia[].Schizophrenia Research.1990
  • 6Addington D,AddingtonJ,Maticka TE.Reliability and validity of a depression rating scale for schizophrenics[].Schizophrenia Research.1992
  • 7Addington D,Addington J,Maticka TE.Specificity of the Cal-gary Depression Scale for schizophrenica[].Schizophrenia Research.1994
  • 8Stauffer VL,Case M,Kimn BJ,et al. Early resix)nse to araipsycl~)tic theray as a clinical marker of subsequent response in the treatment of patients with first-spisode psychosis [ J 1. Psychiatry Res, 2011,187 ( 1 - 2 ) :42 - 48.
  • 9Kion BJ ,Chen L ,Ascher-Svanum H,et al. Predicting response to atypical antipsychotics based on early response in the treatment of schizophrenia [ J ]. Schizophrenia Res, 2008,102 (1 -3) :230 -240.
  • 10范肖东,汪向东,许又新,等.ICD-10精神与行为障碍分类:临床描述与诊断要点[M].北京:人民卫生出版社,1993:72—79.

共引文献62

同被引文献15

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部